Title

Diagnosis and Treatment of Acute and Chronic Heart Failure

Authoring Organization

Publication Month/Year

August 25, 2023

Last Updated Month/Year

August 29, 2023

Document Type

Guideline

Country of Publication

European

Document Objectives

Since the publication of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, there have been several randomized controlled trials that should change patient management ahead of the next scheduled full guideline. This 2023 Focused Update addresses changes in recommendations for the treatment of HF because of this new evidence. We considered new  published evidence up until the 31 March 2023. After considering and discussing many new  major randomized controlled clinical trials and meta-analyses, the Task Force voted to include those that would lead to Class IIa and I recommendations. This has led to us updating some of our guidance for the treatment of HFmrEF, HFpEF, comorbidities and Acute HF.

Inclusion Criteria

Male, Female, Adult, Older adult

Health Care Settings

Ambulatory, Hospital, Outpatient

Intended Users

Nurse, nurse practitioner, physician, physician assistant

Scope

Diagnosis, Treatment, Management

Diseases/Conditions (MeSH)

D006333 - Heart Failure

Keywords

heart failure, acute heart failure

Source Citation

Theresa A McDonagh and others, 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC, European Heart Journal, 2023;, ehad195, https://doi.org/10.1093/eurheartj/ehad195